Download PDF
Rev Bras Ginecol Obstet 2016; 38(02): 112-116
DOI: 10.1055/s-0035-1571174
Case Report
Thieme Publicações Ltda Rio de Janeiro, Brazil

Lobular Carcinoma in Situ with Atypical Mass Presentation: a Case Report

Carcinoma lobular in situ com apresentação nodular atípica: relato de caso
Luciana Graziano
1   Department of Imaging, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
,
Almir Galvão Vieira Bitencourt
1   Department of Imaging, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
,
Camila Souza Guatelli
1   Department of Imaging, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
,
Juliana Alves Souza
1   Department of Imaging, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
,
Cynthia Aparecida Bueno de Toledo Osório
2   Department of Pathology, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
,
Miriam Rosalina Brites Poli
1   Department of Imaging, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
,
Elvira Ferreira Marques
1   Department of Imaging, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

08 July 2015

04 November 2015

Publication Date:
03 February 2016 (online)

   Permissions and Reprints

Abstract

Lobular carcinoma in situ (LCIS) is associated with an increased risk of breast cancer and accounts for 1 to 2% of all breast cancers. LCIS diagnosis currently remains one of the major identifiable risk factors for subsequent breast cancer development. Imaging methods are becoming increasingly sensitive, and the consequent detection of small lesions and subtle abnormalities increases the chance of detection of in situ and invasive carcinomas, leading to a reduction in mortality. This report describes a case of a palpable complaint with abnormal imaging findings, including a solid LCIS mass.

Resumo

O Carcinoma Lobular in situ (CLIS) está associado a um aumento do risco de câncer de mama e representa 1-2% de todas as neoplasias mama. Atualmente, o diagnóstico de CLIS continua a ser um dos maiores fatores de risco identificáveis para o posterior desenvolvimento de câncer de mama. Os métodos de imagem estão cada vez mais sensíveis, fazendo com que a detecção de pequenas lesões e anormalidade sutis aumentem o risco de detecções de carcinomas in situ e invasivos, levando a diminuição da mortalidade. Neste relato será descrito um caso de queixa clínica palpável com alteração de achados de imagem como massa sólida de CLIS.

Keywords

breast - cancer - breast ultrasound - mammography

Palavras-chave

mama - carcinoma - ultrassonografia mamária - mamografia
 

  • References

  • 1 Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?. Mod Pathol 2003; 16 (2) 120-129
    CrossrefPubMedGoogle Scholar
  • 2 Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. Radiology 2004; 231 (3) 813-819
    CrossrefPubMedGoogle Scholar
  • 3 Jorns J, Sabel MS, Pang JC. Lobular neoplasia: morphology and management. Arch Pathol Lab Med 2014; 138 (10) 1344-1349
    CrossrefPubMedGoogle Scholar
  • 4 Chaudhary S, Lawrence L, McGinty G, Kostroff K, Bhuiya T. Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy. Mod Pathol 2013; 26 (6) 762-771
    CrossrefPubMedGoogle Scholar
  • 5 Zhang X, Hanamura N, Yamasita M, Kashikura Y, Ogawa T, Taizo S. A case of lobular carcinoma in situ presenting as a solid mass. Br J Radiol 2011; 84 (999) e48-e50
    CrossrefPubMedGoogle Scholar
  • 6 Cutuli B, De Lafontan B, Kirova Y , et al. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiat Oncol 2015; 10 (1) 110
    CrossrefPubMedGoogle Scholar
  • 7 Beute BJ, Kalisher L, Hutter RV. Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR Am J Roentgenol 1991; 157 (2) 257-265
    CrossrefPubMedGoogle Scholar
  • 8 O'Neil M, Madan R, Tawfik OW, Thomas PA, Fan F. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases. Ann Diagn Pathol 2010; 14 (4) 251-255
    CrossrefPubMedGoogle Scholar
  • 9 Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer 2013; 119 (5) 1073-1079
    CrossrefPubMedGoogle Scholar
  • 10 Nagi CS, O'Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM. Lobular neoplasia on core needle biopsy does not require excision. Cancer 2008; 112 (10) 2152-2158
    CrossrefPubMedGoogle Scholar
  • 11 Stein LF, Zisman G, Rapelyea JA, Schwartz AM, Abell B, Brem RF. Lobular carcinoma in situ of the breast presenting as a mass. AJR Am J Roentgenol 2005; 184 (6) 1799-1801
    CrossrefPubMedGoogle Scholar
  • 12 Christiano JG, Duncan LD, Bell JL. Lobular carcinoma in situ of the breast presenting as a discrete mass. Am Surg 2012; 78 (1) E38-E40
    PubMedGoogle Scholar
  • 13 Lakhani SR, Audretsch W, Cleton-Jensen AM , et al; EUSOMA. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?. Eur J Cancer 2006; 42 (14) 2205-2211
    CrossrefPubMedGoogle Scholar
  • 14 O'Driscoll D, Britton P, Bobrow L, Wishart GC, Sinnatamby R, Warren R. Lobular carcinoma in situ on core biopsy-what is the clinical significance?. Clin Radiol 2001; 56 (3) 216-220
    CrossrefPubMedGoogle Scholar
  • 15 Snyder RE. Mammography and lobular carcinoma in situ. Surg Gynecol Obstet 1966; 122 (2) 255-260
    PubMedGoogle Scholar
  • 16 Hutter RV, Snyder RE, Lucas JC, Foote Jr FW, Farrow JH. Clinical and pathologic correlation with mammographic findings in lobular carcinoma in situ. Cancer 1969; 23 (4) 826-839
    CrossrefPubMedGoogle Scholar
  • 17 Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000; 216 (3) 831-837
    CrossrefPubMedGoogle Scholar
  • 18 Foote FW, Stewart FW. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 1941; 17 (4) 491-496 , 3
    PubMedGoogle Scholar
  • 19 McDivitt RW, Hutter RV, Foote Jr FW, Stewart FW. In situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. JAMA 1967; 201 (2) 82-86
    CrossrefPubMedGoogle Scholar
  • 20 Logan GJ, Dabbs DJ, Lucas PC , et al. Molecular drivers of lobular carcinoma in situ. Breast Cancer Res 2015; 17: 76
    CrossrefPubMedGoogle Scholar
  • 21 Blair SL, Emerson DK, Kulkarni S, Hwang ES, Malcarne V, Ollila DW. Breast surgeon's survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ. Breast J 2013; 19 (1) 116-118
    CrossrefPubMedGoogle Scholar
  • 22 Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 2005; 29 (4) 534-543
    CrossrefPubMedGoogle Scholar
  • 23 Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy—clinical significance. Cancer 2004; 101 (2) 242-250
    CrossrefPubMedGoogle Scholar
  • 24 Zhao C, Desouki MM, Florea A, Mohammed K, Li X, Dabbs D. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol 2012; 138 (1) 72-78
    CrossrefPubMedGoogle Scholar
  • 25 Destounis SV, Murphy PF, Seifert PJ , et al. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR Am J Roentgenol 2012; 198 (2) 281-287
    CrossrefPubMedGoogle Scholar
  • 26 Oppong BA, King TA. Recommendations for women with lobular carcinoma in situ (LCIS). Oncology (Williston Park) 2011; 25 (11) 1051-1056 , 1058
    PubMedGoogle Scholar